tm logo
FLONASE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 29 Jul 2022

Last Applicant/ Owned by

BUILDING 5, FIRST FLOOR, THE HEIGHTS

WEYBRIDGE, SURREY

KT13 0NY

Serial Number

86746149 filed on 02th Sep 2015

Registration Number

4959825 registered on 17th May 2016

in the Principal Register

Correspondent Address

Arrielle S. Siolos

Arrielle S. Siolos

WNJ0200

184 Liberty Corner Road

Warren NJ 07059

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

FLONASE

Pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of respiratory disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of respiratory disorders


First Use Date in General

04th Feb 2015

First Use Date in Commerce

04th Feb 2015

Mark Details


Serial Number

No 86746149

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 81238031

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.15.13 -

More than one polygon

26.15.16 -

Polygons touching or intersecting

26.15.21 -

Polygons that are completely or partially shaded

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
17th Jan 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
17th May 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09th Nov 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
09th Nov 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09th Nov 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09th Nov 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Nov 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29th Jul 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29th Jul 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
29th Jul 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED